15min Glycosylated Hemoglobin Test Kit 3％-14％ HbA1c Rapid Quantitative Test
Brand Name:ZOSBIO
Certification:CE
Model Number:HbA1c
Minimum Order Quantity:To be negotiated
Delivery Time:To be negotiated
Place of Origin:Henan
Contact Now
Add to Cart
Active Member
Location:
Zhengzhou Henan China
Address:
Office Address: Building 4, No. 51 Jingbei 3rd Road, Jingkai Zone, Zhengzhou City. Henan Province,China.
Supplier`s last login times:
within 47 hours
Product Details
Company Profile
Product Details
Overview of HbA1c
Glycated hemoglobin (HbA1c) is blood red blood cells in the product of hemoglobin and serum carbohydrate combination, the combination of blood glucose and hemoglobin generated glycosylated hemoglobin is irreversible reaction, the reaction is proportional to the concentration of blood glucose, and can keep 120 days or so, so glycosylated hemoglobin test can reflect the nearly 8 ~ 12 weeks in patients with blood sugar control.
HbA1c Performance Index
| Detection range | sample size | Sample type | Test time |
| 3％~14％ | 10μl | Whole Blood | 15min |
Clinical significance of HbA1c
- Evaluation of the efficacy of glucose control regimens
- Differentiation between stress hyperglycemia and diabetes
- The diagnosis, treatment and monitoring of gestational diabetes mellitus (GDM)
| Glycated hemoglobin control objectives | Adapt to the crowd |
| <6% | ① Newly diagnosed, young, no complications and associated diseases, no adverse reactions such as hypoglycemia and weight gain in hypoglycemic treatment; ② Patients without hypoglycemic drug intervention; (3) diabetes mellitus with pregnancy; (4) diabetes mellitus found during pregnancy |
| <6.5% | ①<65 years old, no diabetes complications and serious associated diseases; ② Plan patients with gestational diabetes |
| <7% | ① Patients younger than 65 years of age receiving insulin treatment; ②≥65 years old, no risk of hypoglycemia, good organ function, and >15 years survival; (3) GDM patients who planned to receive insulin therapy |
| ≤7.5% | People with existing or very high risk of cardiovascular disease |
| <8% | ≥65 years old, expected survival period is 5-15 years |
| <9% | ①≥65 years old or with malignant tumor, expected survival <5 years; ② high-risk group of hypoglycemia; ③ Difficulties in implementing treatment programs, such as mental or intellectual or visual impairment, poor medical conditions, etc |
Application Department
Cardiology, laboratory, emergency, ICU, oncology, Nephrology,Pediatrics, endocrinology, gynecology, geriatrics, respiratory, thoracic surgery,Gastroenterology, Urology, etc
Clinical comparison of HbA1c
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.
15min Glycosylated Hemoglobin Test Kit 3％-14％ HbA1c Rapid Quantitative Test
Inquiry Cart
0